Holen Sie sich die Stockscreener-App
0.8716
3.28%
-0.0296
Handel nachbörslich:
.89
0.0184
+2.11%
Schlusskurs vom Vortag:
$0.9012
Offen:
$0.8905
24-Stunden-Volumen:
1.19M
Relative Volume:
0.87
Marktkapitalisierung:
$166.28M
Einnahmen:
$4.71M
Nettoeinkommen (Verlust:
$-58.01M
KGV:
-1.0585
EPS:
-0.8234
Netto-Cashflow:
$-46.68M
1W Leistung:
-3.97%
1M Leistung:
-18.54%
6M Leistung:
-26.76%
1J Leistung:
-10.93%
1-Tages-Spanne:
$0.8605
$0.9035
1-Wochen-Bereich:
$0.8605
$0.9396
52-Wochen-Spanne:
$0.8605
$1.6293
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Firmenname
Lucid Diagnostics Inc
Sektor
Branche
Telefon
212 949 4319
Adresse
360 MADISON AVENUE, NEW YORK
Compare LUCD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
0.8716 | 172.34M | 4.71M | -58.01M | -46.68M | -0.8234 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-27 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2021-11-08 | Eingeleitet | BTIG Research | Buy |
| 2021-11-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-11-08 | Eingeleitet | Needham | Buy |
Lucid Diagnostics Inc Aktie (LUCD) Neueste Nachrichten
LUCD|Lucid Diagnostics Inc|Price:0.904|Chg%:-0.003 - TradingKey
Lucid Diagnostics Inc (LUCD) Institutional Confidence - TradingKey
Lucid Diagnostics Inc (LUCD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Lucid Diagnostics Inc (LUCD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lucid Diagnostics Inc (LUCD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lucid Diagnostics Inc (LUCD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lucid Diagnostics Market Sentiment - Benzinga España
Lucid Diagnostics Inc (LUCD) Cash Flow - TradingKey
Lucid Diagnostics Inc (LUCD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
LUCD|Lucid Diagnostics Inc|Price:0.908|Chg%:-0.038 - TradingKey
AAPL: Apple Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Lucid Diagnostics (LUCD) Drops 6.4% to $0.95 – Testing Key SupportAnalyst Upgrade Stocks - dars.gov.et
Lucid Diagnostics (LUCD) Nears One-Dollar Threshold After Modest DeclineArms Index - dars.gov.et
LUCD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Lucid Diagnostics (LUCD) Holds Steady Near Support: Can the Modest Uptick Signal a Reversal?Volume Breadth - dars.gov.et
LUCD Q1 2026 Earnings: Significant EPS Miss and No Reported Revenue Raise ConcernsTech Earnings Analysis - dars.gov.et
Lucid Diagnostics (LUCD) Extends Decline: Approaching Key Support at $0.99 After 3.7% DropKeltner Channel - dars.gov.et
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - GuruFocus
LUCD Q1 2026 Earnings: Significant Earnings Miss as Company Reports No RevenueEstimate Accuracy - DonanımHaber
PAVmed gets 180-day extension to regain Nasdaq listing compliance - MSN
Lucid Diagnostics (LUCD) Edges Higher as Diagnostics Sector Sees Renewed InterestStop Loss Guidance - dars.gov.et
Lucid Diagnostics: Positioned For A Medicare-Driven Inflection (NASDAQ:LUCD) - Seeking Alpha
LUCD News | LUCID DIAGNOSTICS INC (NASDAQ:LUCD) - ChartMill
Lucid Diagnostics Inc.(NasdaqCM:LUCD) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Lucid Diagnostics Inc.(NasdaqCM: LUCD) dropped from Russell 3000 Value Benchmark - marketscreener.com
Lucid Diagnostics Inc.(NasdaqCM: LUCD) dropped from Russell 2500 Value Benchmark - marketscreener.com
Lucid Diagnostics Inc.(NasdaqCM: LUCD) dropped from Russell 2000 Value Benchmark - marketscreener.com
Lucid Diagnostics Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Pre-Revenue Challenges - dars.gov.et
Lucid Diagnostics Inc.(NasdaqCM:LUCD) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Lucid Diagnostics Inc. Actuals & Estimates (NASDAQ:LUCD) - TradingView
LUCD Forecast — Price Target — Prediction for 2027 - TradingView
Lucid Diagnostics Shareholders Approve Stock Authorization Increase - TipRanks
Lucid Diagnostics (LUCD) boosts authorized shares to 400M and re-elects directors - Stock Titan
LUCD: All proposals passed, including director elections and share authorization increase - TradingView
Transcript : Lucid Diagnostics Inc.Shareholder/Analyst Call - marketscreener.com
Lucid Diagnostics (LUCD) Holds Steady at $1.03: Stock Consolidates Near Key LevelsPre-Earnings Momentum - dars.gov.et
LUCD Q1 2026 Earnings: Wider-Than-Expected Loss Drives Stock Despite No RevenueSubscription Growth Report - dars.gov.et
Top Lucid Diagnostics (LUCD) Competitors 2026 - MarketBeat
Lucid Diagnostics Inc (LUCD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lucid Diagnostics Inc (LUCD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lucid Diagnostics Inc (LUCD) Valuation: PE, PB & Fair Value Analysis - TradingKey
LUCD Q1 2026 Earnings: Deep EPS Miss Masks Operational Progress; Stock Edges HigherQuarterly Earnings - DonanımHaber
Lucid Diagnostics (LUCD) Edges Higher, Testing Key Resistance at $1.05Risk Reward Setups - dars.gov.et
LUCD Q1 2026 Earnings: EPS Misses Estimates by 100.7% as Company Reports No RevenueEarnings Turnaround - dars.gov.et
Certain Stock Options of Lucid Diagnostics Inc. are subject to a Lock-Up Agreement Ending on 9-JUN-2026. - marketscreener.com
Lucid Diagnostics misses on revenue, but 2026 growth outlook lights up bull case - MSN
Lucid Diagnostics Misses On Revenue, But 2026 Growth Outlook Lights Up Bull Case - Benzinga
LUCD Maintained by Ascendiant Capital -- Price Target Raised to $9.25 - GuruFocus
LUCD Q1 2026 Earnings: Significant EPS Miss Amid Pre-Revenue Development StageEBITDA Estimate Trend - dars.gov.et
Why Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results - Yahoo Finance
Finanzdaten der Lucid Diagnostics Inc-Aktie (LUCD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lucid Diagnostics Inc-Aktie (LUCD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Matheis Dennis | Director |
Aug 20 '25 |
Buy |
1.02 |
100,000 |
101,840 |
665,443 |
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):